Systemic Juvenile Idiopathic Arthritis‐Lung Disease: Characterization and Risk Factors
An American College of Rheumatology Reading Room selection
Related Articles
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
TikTok points researcher toward signal of benefit
Opinion | Reproducibility in Medical AI: An Open, Democratic Future Is Essential
We need evidence over hype before integrating artificial intelligence into care
Addiction to Screen Time Tied to Suicidality in U.S. Kids
Kids with addictive use of cell phones, social media, video games have worse mental health
Many Diseases We Treat Are Rare, But Patients Are Not Alone
Anyone living through the pandemic 5 years ago can understand the impact that social interactions or lack thereof can have on well-being and mental health.…
Cannabis-CVD Link Holds Strong Amid Changing Drug Laws, User Habits
Real-world reports since 2016 analyzed in updated meta-analysis
GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology
Diet and exercise no longer the main first-line strategies for weight management
Proposed Medicaid Cuts Would Result in Thousands of Preventable Deaths, Study Finds
Study also shows 1.3 million would forego their medications after losing coverage
Removed ACIP Members Say ‘U.S. Vaccine Program Critically Weakened’
All 17 dismissed panelists pen JAMA Viewpoint
Brain Surgery and D.C. Strategy: A Q&A With AMA President Bobby Mukkamala
The AMA’s new president talks about his personal health journey and the policy challenges ahead
Joanna Melia, MD, on Boosting Treatment Responses in Refactory IBD
Clinical trials of new biologics in patients with inflammatory bowel disease (IBD), such as upadacitinib (Rinvoq), have shown promising results, with remission rates from 50%-80%.…